Heart Failure

Clinical Trial Finder

Many patients with heart failure are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Condition:   Congestive Heart Failure
Interventions:   Drug: OPC-61815 injection 2mg;   Drug: OPC-61815 injection 4mg;   Drug: OPC-61815 injection 8mg;   Drug: OPC-61815 injection 16mg;   Drug: Tolvaptan tablet 15mg
Sponsor:   Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified August 2017

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)

Condition:   Heart Failure With Preserved Ejection Fraction
Interventions:   Drug: IW-1973;   Drug: Placebo Oral Tablet
Sponsor:   Ironwood Pharmaceuticals, Inc.
Not yet recruiting - verified June 2017

Survey of QRS Frequency at Various Left Ventricular Pacing Sites for Cardiac Resynchronization

Conditions:   Cardiomyopathies;   Congestive Heart Failure
Intervention:   Device: Biotronik Vision Guidewire
Sponsor:   The Cleveland Clinic
Recruiting - verified August 2017

High-intensity vs. Low-intensity Inspiratory Muscle Training in Patients With Heart Failure

Condition:   Heart Failure
Interventions:   Other: High-intensity IMT + Aerobic/resistance exercise;   Other: Low-intensity IMT + Aerobic/resistance exercise;   Other: Sham IMT + Aerobic/resistance exercise
Sponsor:   Federal University of Bahia
Recruiting - verified August 2017

ConnectedHeartHealth - Heart Failure Readmission Intervention

Conditions:   Diabetes Mellitus;   Coronary Artery Disease;   Heart Failure
Intervention:   Behavioral: Ambio Health Remote Monitoring
Sponsors:   LifeBridge Health;   American Heart Association (AHA)
Recruiting - verified August 2017

HIIT Improves Survival of Heart Failure Patients

Conditions:   Heart Failure;   Cardiac Rehabilitation;   Cardiac Remodeling, Ventricular
Intervention:   Behavioral: High-intensity interval training
Sponsors:   Chang Gung Memorial Hospital;   Ministry of Science and Technology, Taiwan
Completed - verified August 2017

Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Canagliflozin;   Drug: Empagliflozin;   Drug: Dapagliflozin;   Drug: Dipeptidyl Peptidase-4 Inhibitor (DPP-4);   Drug: Glucagon-Like Peptide-1 Agonist (GLP-1);   Drug: Thiazolidinedione (TZD);   Drug: Sulfonylureas;   Drug: Insulin
Sponsor:   Janssen Research & Development, LLC
Active, not recruiting - verified August 2017

Follow-up of Arthrosurface HemiCAP Implants

Condition:   Orthopedic Disorder
Intervention:  
Sponsors:   The Cleveland Clinic;   Arthrosurface, Inc.
Recruiting - verified July 2017

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points